Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 35 | 3,475−14%/yr | −14%/yr | 5.11.1× | 60% | 2,970 in 2030−2.6%/yr |
| Peripheral arterial intervention |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 18 |
| 2,941−9.6%/yr |
| −9.6%/yr |
| 4.01.0× |
| 16% |
| 2,980 in 2030+0.2%/yr |
| Superficial venous ablation | 29 | 2,244−3.2%/yr | −3.2%/yr | 3.00.9× | 86% | 2,540 in 2030+2.1%/yr |
| Thrombectomy, IVC filters & venous stents | 7 | 1,264+6.5%/yr | +6.5%/yr | 1.81.3× | 15% | 1,940 in 2030+7.4%/yr |
| Carotid revascularization | 20 | 960−7.3%/yr | −7.3%/yr | 1.31.2× | 0% | 930 in 2030−0.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 4 | 350−7.1%/yr | −7.1%/yr | 0.51.1× | 0% | 380 in 2030+1.5%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.